These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15850973)

  • 1. Exelixis: integrated drug-discovery and development platform for human therapeutics.
    McCarthy AA
    Chem Biol; 2005 Apr; 12(4):407-8. PubMed ID: 15850973
    [No Abstract]   [Full Text] [Related]  

  • 2. Deal watch: Bristol-Myers Squibb and Exelixis collaborate on kinase inhibitors.
    Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180098
    [No Abstract]   [Full Text] [Related]  

  • 3. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead validation platforms.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT47-9. PubMed ID: 11221718
    [No Abstract]   [Full Text] [Related]  

  • 5. Marine natural products: drugs from the deep.
    Marris E
    Nature; 2006 Oct; 443(7114):904-5. PubMed ID: 17066005
    [No Abstract]   [Full Text] [Related]  

  • 6. Biodiscovery--from reef to outback.
    Blake D
    Nature; 2004 Jun; 429(6991 Suppl):15-7. PubMed ID: 15175706
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of natural products to future pharmaceutical discovery.
    Baker DD; Chu M; Oza U; Rajgarhia V
    Nat Prod Rep; 2007 Dec; 24(6):1225-44. PubMed ID: 18033577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining priorities in gene-based drug discovery.
    Khodadoust MM; Klein TP
    Nat Biotechnol; 2001 Aug; 19(8):707. PubMed ID: 11479549
    [No Abstract]   [Full Text] [Related]  

  • 9. Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology.
    van der Greef J; McBurney RN
    Nat Rev Drug Discov; 2005 Dec; 4(12):961-7. PubMed ID: 16341061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the human genome on the discovery of immune-modulatory therapeutics.
    Manning AM
    Curr Opin Investig Drugs; 2006 May; 7(5):406-11. PubMed ID: 16729715
    [No Abstract]   [Full Text] [Related]  

  • 12. China's unique position in discovery and preclinical research.
    Boutellier R; Ullman F
    Drug Discov Today; 2007 Jan; 12(1-2):4-7. PubMed ID: 17198968
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of medicinal chemists in drug discovery.
    Greenlee WJ; Desai MC
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):419-20. PubMed ID: 16022177
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
    Razvi ES
    IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
    [No Abstract]   [Full Text] [Related]  

  • 15. An integrated network-based mechanistic model for tumor growth dynamics under drug administration.
    Ribeiro D; Pinto JM
    Comput Biol Med; 2009 Apr; 39(4):368-84. PubMed ID: 19285661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragmentary solutions. Astex therapeutics puts the pieces together.
    Wolfson W
    Chem Biol; 2006 Aug; 13(8):799-801. PubMed ID: 16931326
    [No Abstract]   [Full Text] [Related]  

  • 17. Data management solutions for protein therapeutic research and development.
    Vielmetter J; Tishler J; Ary ML; Cheung P; Bishop R
    Drug Discov Today; 2005 Aug; 10(15):1065-71. PubMed ID: 16055023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. India takes an open source approach to drug discovery.
    Singh S
    Cell; 2008 Apr; 133(2):201-3. PubMed ID: 18423188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
    Glah D; Tear S
    IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888
    [No Abstract]   [Full Text] [Related]  

  • 20. Break with tradition.
    Jayaraman KS
    Nature; 2006 Jul; 442(7101):342-3. PubMed ID: 16871181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.